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Stereoselective synthesis of 1,2-diamine
containing indolines by a conjugate addition
nitro-mannich reaction†
James C. Anderson,*a Ian B. Campbell,b Sebastien Campos,b Jonathan Shannona
and Derek A. Tocher‡a
A conjugate addition nitro-Mannich reaction followed by nitro reduction and intramolecular N-arylation
gives diastereomerically pure substituted 1,2-diamine containing indolines. Placing the N-arylation cycli-
sation handle on the imine precursor derived from an ortho-bromine substituted aromatic aldehyde gave
the corresponding β-nitroamines in 55–72% yields as single diastereoisomers. Nitro reduction was
eﬀected with modiﬁed quantities of Zn/HCl and a subsequent Pd(0) catalysed Buchwald Hartwig cyclisa-
tion gave indoline products in 40–70% yields as single diastereoisomers.
Introduction
The nitro-Mannich (or aza-Henry) reaction has emerged as
a reliable and predictable reaction for the synthesis of β-nitro-
amines in stereochemically pure form.1,2 These products have
proven useful in the synthesis of many nitrogen containing
functional groups including 1,2-diamines,3–10 α-amino
carbonyls,11–13 peptidomimetics,14 natural products15–20 and
many heterocyclic small molecules21–32 of importance to drug
discovery. The anti-diastereoisomer dominates with higher
homologues of nitromethane, with there being only a few
methods for syn-selective nitro-Mannich reactions.26,33–35 We
reported the enantioselective alkyl conjugate addition nitro-
Mannich reaction of dialkyl zincs to nitroalkenes to synthesise
complex β-nitroamines containing three contiguous stereo-
centres (Scheme 1).36 The judicious choice of solvent determined
whether the syn,anti- or syn,syn-diastereoisomer was formed and
provided another method for the synthesis of syn-β-nitroamines.
As part of an investigation into using the nitro-Mannich reaction
in diversity-oriented array synthesis, we were interested in the syn-
thesis of arrays of stereochemically diverse fused heterocyclic ring
systems. We have recently shown that the reductive nitro-
Mannich reaction with arylbromide nitrostyrenes can deliver
stereodefined functionalised diamine building blocks that are
precursors to either 3-aminotetrahydroquinolines or 2-amino-
methylene indolines via N-arylation (Scheme 1).37
We detail here our investigation into the combination of the
alkyl conjugate addition nitro-Mannich reaction with suitable
aryl bromide containing coupling partners and their subsequent
intramolecular cyclisation by palladium catalysed N-arylation to
yield novel drug like heterocyclic ring systems (Scheme 2).
Results and discussion
Using conditions previously developed by us, the simplest
2-bromonitrostyrene (1a) underwent smooth Cu(OTf)2 cata-
lysed (5 mol%) conjugate addition of ZnEt2 (1.1 equiv.) as
judged by TLC. The resultant nitronate species was then
reacted with PMP protected imine 2a (2.2 equiv.) and TFA (2.6
equiv.) with quenching at −78 °C. Crude 3aa was isolated in a
60 : 40 ratio of two of the possible four diastereoisomers, deter-
mined by 1H NMR (Scheme 3). Preliminary investigation of the
reaction conditions varied the temperature after TFA addition
and the time before quenching. The selectivity tended towards
1 : 1 and the crude product was unstable over time, reverting to
starting materials.38 Usually formation of the corresponding
trifluoroacetamide leads to an isolable product, but in this
instance the instability of 3aa and the reluctance of similar
syn,syn-diastereoisomers to be protected, led to the isolation of
only 34% of the syn,anti-4aa diastereoisomer as a single
diastereoisomer.36,§ This product was most likely the minor
diastereoisomer in the mixture of 3aa.
†Electronic supplementary information (ESI) available: General experimental
details, X-ray representations and copies of 1H and 13C NMR spectra. CCDC
1020679. For ESI and crystallographic data in CIF or other electronic format see
DOI: 10.1039/c4ob01793e
‡Corresponding author for crystallographic results.
aDepartment of Chemistry, University College London, 20 Gordon Street, London,
WC1H 0AJ, UK. E-mail: j.c.anderson@ucl.ac.uk
bGlaxoSmithKline, Medicines Research Centre, SG1 2NY Stevenage, UK
§β-Nitroamines without electron withdrawing protecting groups on nitrogen are
known to be unstable to standard purification techniques and undergo retro-
addition. See ref. 7 and 36.
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A screen of diﬀerent protecting groups of the imine partner
2 (COPh, CO2Bn, POPh2) along with various Lewis and
Bronsted acid promoters in place of TFA (AcOH, CF3SO3H,
MeSO3H, Yb(OTf)3, AlCl3, Zn(OTf)2, BF3·Et2O) was undertaken.
Disappointingly no conditions were found that gave either
high conversion or a good level of diastereoselectivity with the
2-bromonitrostyrene (1a). These results were similar to what
we had found in our earlier work with other ortho-substituted
nitrostyrenes.36
An alternative cyclisation precursor was envisaged where
the halide coupling partner was part of the aldehyde that the
imine was derived from. This small change had a dramatic
eﬀect on the extent of diastereoselectivity, and stability of the
nitro-Mannich product (Scheme 4). Complete consumption of
1b was verified by TLC and the reaction went to complete con-
version as judged by 1H NMR. The diastereoselectivity of the
crude product did not change over reaction time or tempera-
ture after addition of TFA, indicating that the major stereo-
isomer was thermodynamically stable. We tentatively assigned
the stereochemistry as the syn,syn-diastereoisomer by analogy
to previous work where we found that this particular diastereo-
isomer was relatively stable and could be purified by column
chromatography to give diastereomerically pure material.36
With 2 equivalents of imine 2b the major diastereoisomer syn,
syn-3bb could be isolated in 72% yield¶ and the relative stereo-
chemistry was confirmed by single crystal X-ray analysis (see
Scheme 1 Previous work.
Scheme 2 Proposed array synthesis of complex heterocycles.
Scheme 3 Preliminary conjugate addition nitro-Mannich reaction.
Scheme 4 Stable cyclisation precursor.
¶A minor diastereoisomer was also isolated in 10% yield and is tentatively
assigned anti,syn-3bb, by analogy to other work (ref. 36), which has been more
rigorously corroborated with single crystal X-ray crystallography. This is based
upon the diastereosiomer being stable to purification, so most probably has the
syn-relative stereochemistry across the nitro-amine bond.
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ESI†). Reducing the quantity of imine 2b to 1.1 equivalents led
to no change in crude diastereoselectivity (85 : 15), but the
major compound was significantly easier to purify and was iso-
lated in 68% yield.
A solvent screen (see ESI†) showed that Et2O gave the
highest diastereoselectivity followed by toluene (80 : 20), which
contained more side products and unlike Et2O was a homo-
genous solution. Other solvents which gave homogeneous
reaction mixtures did not give as the major diastereoisomer
the syn,anti-product which had been previously observed with
very similar substrates.36 In most cases the syn,syn-diastereo-
isomer was the major compound to varying degrees and all
attempts at protection of the amine as a trifluoroacetamide
were unsuccessful, which is in agreement with our previous
observations for this particular diastereoisomer.36
Intramolecular N-arylation required the reduction of the
nitro function to an amine. Investigations commenced with
3bb and initial conditions we have developed for the reduction
of β-nitroamines into 1,2-diamines using Zn/HCl (Scheme 5,
conditions A).36–38 Although the nitro group was completely
reduced, a 1 : 1 mixture of the desired amine 5bb and the deb-
rominated material 6 were obtained. Optimisation studies
found that reducing the amount of reductant zinc, but increas-
ing the relative amount of HCl lead cleanly to the desired
diamine. Normally β-nitroamines (like 3bb) would be isolated
as their corresponding trifluoroacetamides and subsequent
reduction is accompanied by migration of the trifluoroacetyl
group to the primary nitrogen, giving a stable isolable
product.36–38 However, as the syn,syn-diastereoisomers like 3bb
are in general inert to trifluoroacetylation,36 the resultant 1,2-
diamine reduction product 5bb was found to become less pure
upon column chromatography. As a consequence intramole-
cular cyclisation using palladium catalysed N-arylation was
attempted on the crude reduction material.
Treatment of 5bb under standard Pd(PPh3)4 Buchwald–
Hartwig conditions that we have used to perform analogous
cyclisations (Scheme 1),37 led cleanly to the indoline 7bb by 1H
NMR of the crude cyclisation product (Scheme 6). Initial
attempts at purification using silica gel chromatography led to
degradation and isolation of the corresponding indole 8
(∼25%) as a mixture with p-anisidine. Indoline 7bb is unstable
to acidic conditions, but using basic alumina chromatography
we were able to isolate 7bb in a good 60% yield over two steps
as a single diastereoisomer. Use solely of NaOtBu as base led
to 64% yield of indoline 7bb (Scheme 6).
The scope of this reaction sequence for the synthesis of the
1,2-diamine indolines was then investigated with a series of
aldimines containing an ortho-bromine susbstituent and nitro
styrenes under the optimised conditions described above
(Scheme 7 and Table 1).
The conjugate addition nitro-Mannich reaction proceeds
well with a range of imines 1 and nitrostyrenes 2 to give good
diastereoslectivites of syn,syn-products and good isolated
yields of diastereomerically pure β-nitroamines 3. The
reductions proceeded smoothly except for the β-nitroamine
derived from 2-bromo-3-pyridinylaldehyde (entry 6), which led
to an inseparable mixture of unidentified products. Use of Sn/
HCl gave similar results and Al/Hg amalgam, which we have
used for the reduction of sensitive β-nitroamines,39 gave a
complex mixture of products. No doubt the sensitivity of the
pyridine function and the C–Br bond are both compounding
this reduction. Cyclisations to give the indoline nucleus by
standard Pd(PPh3)4 Buchwald–Hartwig conditions gave good
yields in most cases. The β-nitroamine derived from 2-bromo-
5-methoxy benzaldehyde (entry 3) cyclised using Pd(PPh3)4
albeit with a moderate yield of 40%. The congener derived
from 2-bromo-4,5-dimethoxy benzaldehyde (entry 4) failed to
cyclise and gradually led to decomposition of the β-nitroamine
over longer reaction times. Changing to a Binap or X-Phos
ligand system, which is known to coupling electron rich aryl
bromides,40 also led to gradual decomposition.
With respect to the conjugate addition of other carbon
nucleophiles, we have already shown that methyl and phenyl
dialkylzinc species work in the conjugate addition nitro-
Mannich reaction and led to syn,syn-β-nitroamines in high
diastereoselectivity.36 There are a number of chiral metal cata-
lysed systems that control the enantioselectivity of dialkyl zinc
addition to nitro-alkenes and we have already shown that this
is a good way of making the conjugate addition nitro-Mannich
products enantioselectively,36 which would in turn lead to the
heterocyclic products described here in enantiomerically pure
form. This methodology is limited by the availability of dialkyl-
zincs and although it is possible to add functionalised dialkyl
zincs that can be derived from the tandem hydroboration/
boron-zinc exchange method developed by Knochel,41 it would
Scheme 6 Indoline formation.
Scheme 5 Nitro reduction.
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be better if more readily available carbon nucleophiles could
be found. In an attempt to widen the scope of the reaction to
include organozinc halidesk,42,43 test reactions revealed that
benzylzinc bromide and allylzinc bromide both gave low dia-
stereoselectivities and trace conversions (<10%) with 1b and
2b in THF and Et2O. By TLC the reactions seem to falter at the
conjugate addition stage. Exploration of Grignard reagents was
not successful with vinyl magnesium bromide, but changing
to ethylmagnesium bromide gave an optimised yield of 70%
(Scheme 8), but unfortunately a significant drop in diastereo-
selectivity (60 : 40).
We have found nucleophilic hydride useful in the conjugate
addition nitro-Mannich reaction38,44 and with these particular
substrates use of super hydride® led to anti-β-nitroamine 9,
that could be smoothly reduced and cyclised to give the indo-
line 10 in 75% yield from 9 (Scheme 9). The sense of diastereo-
selection was anti- as previously described for other ortho-
substituted aldimines.38
Conclusion
We have developed a diastereoselective synthesis of substituted
1,2-diamine containing indolines, that represent novel drug
like heterocyclic ring systems, from a conjugate addition nitro-
Mannich reaction followed by nitro reduction and intramole-
cular N-arylation. Attempts to make indoline precursors from
nitro styrenes containing an ortho-bromine substituent were
low yielding and poorly diastereoselective (Scheme 3). Placing
the N-arylation cyclisation handle on the imine precursor
derived from an ortho-bromine substituted aromatic aldehyde
was much more successful giving the corresponding β-nitro-
amine in good yield and as a single diastereoisomer. Nitro
reduction was eﬀected with modified quantities of Zn/HCl and
a subsequent Pd(0) catalysed Buchwald Hartwig cyclisation
gave indoline products in good yields as single diastereo-
isomers (Table 1). Electron rich aryl bromides were found to
be reluctant to cyclise. Despite exploring other more readily
available organometallic carbon nucleophiles, especially orga-
nozinc halides, a limitation to the current methodology is that
dialkyl zinc species are the most eﬃcient for the initial conju-
gate addition to nitro styrene. We have previously modified lit-
erature protocols to enable the enantioselective synthesis of
suitably functionalised β-nitroamines for cyclisation to functio-
nalised heterocycles36,37,44 and this methodology could also be
used in this case. We are investigating the use of other nucleo-
philes to trigger this reaction and alternative cyclisation modes
are being investigated to prepare alternate ring systems and
will be reported in due course.
Scheme 7 Scope of indoline formation.
Table 1 Scope of indoline formationa
Entry Ar1 Ar2
3 dr
crudeb
Yield 3c
(%)
Yield 7c
(%)
1 Ph 2-BrPh 85 : 15 68 64
2 Ph 2-Br-5-FPh 90 : 10 72 53
3 Ph 2-Br-5-MeOPh 80 : 20 63 40
4 Ph 2-Br-4,5-(MeO)2Ph 80 : 20 57 0
d
5 Ph 2-Br-4-MePh 85 : 15 63 64
6 Ph 2-Br-3-pyridinyl 80 : 20 55 0e
7 4-MePh 2-BrPh 80 : 20 64 64
8 2-MePh 2-BrPh 80 : 20 62 66
9 4-FPh 2-BrPh 75 : 25 62 70
aNitro-Mannich: 1 (3 mmol), Cu(OTf)2 (5 mol%), ZnEt2 (1.1 equiv.),
Et2O, −78 °C, 5 min, then RT 2 h; 2 (1.1 equiv.), Et2O, −78 C, 10 min;
TFA (2.6 equiv.), Et2O, −78 °C, 1 h then to RT 1 h. Nitro reduction:
conc. HCl (10 mmol) added to 3 (0.50 mmol), Zinc (4.00 mmol), in
EtOH (7.5 mL) at 0 °C, 5 min then RT. N-arylation: crude 1,2-diamine
in PhMe (1.5 ml) added to NaOtBu (1.00 mmol),
Pd(PPh3)4 (0.025 mmol) in PhMe (1 ml) at RT then 90 °C, 16–24 h.
bDiastereoselectivities were calculated by comparison of the 1H NMR
signals for the CHCHNO2 protons (δ 3.1–3.6 ppm) of the crude
reaction mixture. c Isolated yield of pure syn,syn-diastereoisomer.
d Reaction failed at cyclisation. e Reaction failed at reduction.
Scheme 8 Use of Grignard nucleophile.
Scheme 9 Sequence using the reductive nitro-Mannich reaction.
kAlkyl/aryl zinc halides have been shown to be useful in certain addition and
conjugate addition reactions.
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Experimental section
General procedure for the synthesis of syn,syn-β-nitroamines 3
(Table 1)
To a stirred mixture of nitroalkene (3.00 mmol) and Cu(OTf)2
(0.05 mmol) in Et2O (5 mL) at −78 °C was added Et2Zn
(3.3 mmol, 1 M in hexanes) dropwise. The mixture was stirred
at this temperature for 5 min then at RT until the reaction was
complete by TLC analysis (approximately 2 h). The reaction
mixture was cooled to −78 °C and a solution of imine
(3.3 mmol) in dry Et2O (5 mL) was added and the mixture
stirred for 10 min. Then a solution of TFA (7.8 mmol) in Et2O
(0.2 mL) was added dropwise over 20 s and the reaction stirred
for 1 h. The reaction was warmed to room temperature over
1 h to provide a suspension of white solid in a vivid yellow
supernatant. The reaction was quenched by the addition of
Et2O and saturated aq. NaHCO3. The layers were separated,
and the aqueous phase was extracted with Et2O. The organic
layers were combined, and the solvent was removed in vacuo to
provide crude β-nitroamine. Diastereoselectivities were calcu-
lated by comparison of the 1H NMR signals for the CHCHNO2
protons (δ 3.1–3.6 ppm). Purification by flash chromatography
yielded diastereomerically pure syn,syn-β-nitroamines 3.
syn,anti-4aa (1R*,2S*,3R*)-N-(1-(2-Bromophenyl)-2-nitro-
3-phenylpentyl)-N-trifluoroacetyl-4-methoxybenzenamine. Pre-
pared according to our previously published work on a 3 mmol
scale.38 Pale yellow oil (34%) 1H NMR (600 MHz, CDCl3): δ 0.87
(3H, t, J = 7.3), 1.82 (1H, ddq, J = 13.7, 10.5, 7.3), 2.04 (1H, dqd,
J = 13.7, 7.3, 4.6), 3.77 (3H, s), 4.13 (1H, ddd, J = 10.5, 6.2, 4.5),
5.78 (1H, br. s), 5.90 (1H, m), 5.92 (1H, dd, J = 8.8, 2.7), 6.55
(1H, dd, J = 8.8, 2.9), 6.71 (1H, br. d, J = 8.3), 6.76 (1H, dd, J =
8.8, 2.9), 7.10 (2H, d, J = 7.4), 7.21 (1H, ddd, J = 8.1, 7.2, 1.8),
7.22 (2H, m), 7.29 (1H, tt, J = 7.2, 1.2), 7.34 (1H, ddd, J = 7.8,
7.2, 1.3), 7.38 (1H, dd, J = 7.9, 1.8), 7.67 (1H, dd, J = 8.1, 1.4);
13C NMR (126 MHz, CDCl3): δ 11.5 (CH3), 26.5 (CH2), 45.9
(CH), 55.6 (CH3), 63.6 (CH), 90.0 (CH), 113.6 (CH), 114.1 (CH),
116.2 (CH, d, J = 288.4), 127.2 (q), 128.1 (q), 128.3 (CH), 128.6
(CH), 128.7 (CH), 128.8 (2xCH), 129.4 (CH), 129.5 (2xCH),
130.7 (CH), 131.9 (CH), 133.6 (CH), 134.3 (q), 137.7 (q), 158.4
(CH, d, J = 35.5), 160.2 (q); IR νmax (neat) 2968, 2935, 1695,
1553, 1510, 1254 cm−1; HRMS (EI) calcd for C26H24BrF3N2O4
+,
[M+] 564.0866 found 564.0856.
syn,syn-3bb Entry 1(1S*,2S*,3R*)-N-(1-(2-Bromophenyl)-
2-nitro-3-phenylpentyl)-4-methoxybenzenamine. Yellow solid
(68%) m.p. 117–118 °C; 1H NMR (500 MHz, CDCl3): δ 0.77 (3H,
t, J = 7.3), 1.63 (1H, dqd, J = 13.5, 7.3, 3.6), 1.61 (1H, ddq, J =
13.5, 11.7, 7.3), 3.65 (1H, app. td, J = 11.5, 3.5), 3.66 (3H, s),
4.56 (1H, dd, J = 10.4, 3.2), 5.05 (1H, dd, J = 11.3, 3.4), 6.20
(2H, m), 6.62 (2H, m), 7.07 (2H, m), 7.16 (1H, m), 7.26 (1H, m),
7.45 (1H, d, J = 7.8); 13C NMR (126 MHz, CDCl3): δ 11.4 (CH3),
24.8 (CH2), 47.8 (CH), 55.2 (CH3), 55.7 (CH), 95.2 (CH), 114.0
(2C, CH), 114.5 (2C, CH), 122.8 (CH), 122.8 (q), 127.1 (CH),
127.5 (CH), 127.9 (CH), 128.4 (2C, CH), 128.6 (2C, CH), 129.4
(CH), 132.8 (CH), 136.5 (q), 136.8 (q), 139.1 (q), 152.0 (q); IR
νmax (neat) 3408, 2967, 1550, 1243 cm
−1; HRMS (EI) calcd for
C24H25BrN2O3
+, [M+] 468.1043 found 468.1035. Minor diastereo-
isomer. Pale yellow oil; 1H NMR (600 MHz, CDCl3): δ 0.73 (3H,
t, J = 7.3), 1.74–1.85 (1H, m), 1.97–2.09 (1H, m), 3.61 (1H, app.
td, J = 11.1, 3.8), 3.71 (3H, s), 5.23 (1H, dd, J = 11.1, 3.6), 5.31
(1H, d, J = 9.8), 5.47 (1H, dd, J = 9.8, 3.6), 6.49–6.56 (2H, m),
6.70–6.80 (2H, m), 7.09–7.25 (6H, m), 7.28–7.33 (2H, m),
7.55–7.61 (1H, m); 13C NMR (151 MHz, CDCl3): δ 11.8 (CH3),
24.1 (CH2), 48.4 (CH), 55.6 (OCH3), 55.8 (CH), 95.7 (CH), 114.0
(2C, CH), 115.1 (2C, CH), 123.3 (q), 127.7 (CH), 127.8 (CH),
128.2 (2C, CH), 128.6 (CH), 128.9 (2C, CH), 130.0 (CH), 133.3
(CH), 136.5 (q), 138.5 (q), 139.5 (q), 152.6 (q); IR νmax (neat)
3403, 2967, 1552, 1243 cm−1; HRMS (EI) calcd for
C24H25BrN2O3
+, [M+] 468.1043 found 468.1035.
Entry 2 (1S*,2S*,3R*)-N-(1-(2-Bromo-5-fluorophenyl)-2-nitro-
3-phenylpentyl)-4-methoxybenzenamine. Yellow solid (72%)
m.p. 123–124 °C; 1H NMR (600 MHz, CDCl3): δ 0.76 (3H, t, J =
7.3), 1.63 (1H, dqd, J = 13.4, 7.3, 3.5), 1.80 (1H, dqd, J = 13.4,
11.6, 7.3), 3.64 (1H, td, J = 11.4, 3.5), 3.67 (3H, s), 4.50 (1H, dd,
J = 10.2, 3.3), 5.05 (1H, dd, J = 11.4, 3.3), 5.22 (1H, d, J = 10.2),
6.19–6.22 (2H, m), 6.62–6.65 (2H, m), 6.80 (1H, ddd, J = 8.6,
7.6, 3.0), 7.16 (1H, dd, J = 9.2, 3.0), 7.24–7.30 (5H, m), 7.43 (1H,
dd, J = 8.6, 5.0); 13C NMR (126 MHz, CDCl3): δ 14.2 (CH3), 25.1
(CH2), 48.3 (CH), 55.7 (CH3), 56.2 (CH), 95.2 (CH), 114.3 (2C,
CH), 114.9 (2C, CH), 115.0 (d, JCF = 24.2, CH), 116.9 (d, JCF =
2.7, q), 117.2 (d, JCF = 22.9, CH), 128.0 (CH), 128.9 (2C, CH),
129.0 (2C, CH), 134.5 (d, JCF = 7.7, CH), 137.0 (q), 139.0 (q),
139.6 (d, JCF = 5.9, q), 152.5 (q), 162.5 (d, JCF = 249.0, q); IR
νmax (neat) 3417, 2966, 1550, 1242, cm
−1; HRMS (EI) calcd for
C24H24BrFN2O3
+, [M+] 486.0948 found 486.0934; Anal. calcd
for C24H24BrFN2O3: C, 59.15; H, 4.96; N, 5.75; found: C, 59.09;
H, 4.89; N, 5.78%.
Entry 3 (1S*,2S*,3R*)-N-(1-(2-bromo-5-methoxyphenyl)-2-
nitro-3-phenylpentyl)-4-methoxyaniline. Yellow solid (63%)
m.p. 148–150 °C; 1H NMR (400 MHz, CDCl3): δ 0.75 (3H, t, J =
7.3), 1.63 (1H, dqd, J = 13.5, 7.3, 3.5), 1.80 (1H, ddq, J = 13.5,
11.3, 7.3), 3.56–3.66 (1H, m), 3.64 (3H, s), 3.666 (3H, s), 4.64
(1H, m), 5.06 (1H, dd, J = 11.3, 3.5), 5.20 (1H, br. s), 6.15–6.28
(2H, m), 6.56–6.69 (4H, m), 7.21–7.39 (6H, m); 13C NMR
(101 MHz, CDCl3): δ 11.6 (CH3), 25.2 (CH2), 48.2 (CH), 55.3
(CH3), 55.6 (CH3), 56.2 (CH), 95.5 (CH), 113.1 (q), 113.6 (CH)
114.3 (2C, CH), 114.8 (2C, CH), 115.2 (CH), 127.8 (CH), 128.7
(2C, CH), 128.9 (2C, CH), 133.7 (CH), 137.1 (q), 138.0 (q), 139.5
(q), 152.3 (q), 159.5 (q); IR νmax (neat) 3406, 2935, 1550,
1240 cm−1; HRMS (ES) calcd for C25H28BrN2O4
+, [M + H+]
499.1232 found 499.1236.
Entry 4 (1S*,2S*,3R*)-N-(1-(2-bromo-4,5-dimethoxyphenyl)-
2-nitro-3-phenylpentyl)-4-methoxybenzenamine. Yellow solid
(57%) m.p. 53–55 °C; 1H NMR (600 MHz, CDCl3): δ 0.75 (3H, t,
J = 7.3), 1.62 (1H, dqd, J = 13.5, 7.3, 3.5), 1.79 (1H, ddq, J =
13.5, 11.7, 7.3), 3.60 (1H, td, J = 11.4, 3.5), 3.67 (3H, s), 3.69
(3H, s), 3.80 (3H, s), 4.45 (1H, dd, J = 10.0, 3.4), 5.00 (1H, dd,
J = 11.4, 3.4), 5.19 (1H, d, J = 10.0), 6.20–6.23 (2H, m), 6.55 (1H,
s), 6.60–6.63 (2H, m), 6.90 (1H, s), 7.24–7.29 (5H, m); 13C NMR
(126 MHz, CDCl3): δ 11.7 (CH3), 25.2 (CH2), 48.3 (CH), 55.7
(CH3), 56.1 (CH3), 56.1 (CH), 56.2 (CH3), 95.9 (CH), 109.8 (CH),
114.4 (2C, CH), 114.9 (2C, CH), 115.6 (CH), 127.9 (CH), 128.8
(2C, CH), 128.9 (2C, CH), 134.5 (CH), 137.2 (q), 139.6 (q), 149.0
Paper Organic & Biomolecular Chemistry
174 | Org. Biomol. Chem., 2015, 13, 170–177 This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
0 
O
ct
ob
er
 2
01
4.
 D
ow
nl
oa
de
d 
on
 2
0/
10
/2
01
5 
16
:5
4:
25
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
(q), 149.3 (q), 152.3 (q); IR νmax (neat) 3399, 2965, 1549,
1258 cm−1; HRMS (EI) calcd for C26H29BrN2O5
+, [M+] 528.1254
found 528.1254.
Entry 5 (1S*,2S*,3R*)-N-(1-(2-bromo-4-methylphenyl)-2-nitro-
3-phenylpentyl)-4-methoxyaniline. Yellow solid (63%)
m.p. 97–99 °C; 1H NMR (400 MHz, CDCl3): δ 0.75 (3H, t, J =
7.3), 1.63 (1H, dqd, J = 13.6, 7.3, 3.6), 1.78 (1H, ddq, J = 13.6,
11.3, 7.3), 2.21 (3H, s), 3.57–3.70 (1H, m), 3.65 (3H, s),
4.48–4.57 (1H, m, J = 10.3, 3.3), 5.04 (1H, dd, J = 11.3, 3.5), 5.18
(1H, d, J = 9.3), 6.14–6.27 (2H, m), 6.53–6.67 (2H, m), 6.89–7.00
(2H, m), 7.19–7.32 (6H); 13C NMR (101 MHz, CDCl3): δ 11.6
(CH3), 20.6 (CH3), 25.2 (CH2), 48.2 (CH), 55.6 (CH3), 55.8 (CH),
95.7 (CH), 114.4 (2C, CH), 114.8 (2C, CH, 122.8 (q), 127.0 (CH),
127.8 (CH), 128.7 (2C, CH), 128.9 (2C, CH), 128.9 (CH), 133.6
(CH), 133.7 (q), 137.2 (q), 139.5 (q), 139.9 (q), 152.3 (q); IR νmax
(neat) 3415, 2932, 1550, 1243 cm−1; HRMS (EI) calcd for
C25H28BrN2O3
+, [M + H+] 483.1278 found 483.1283.
Entry 6 (1S*,2S*,3R*)-N-(1-(2-bromopyridin-3-yl)-2-nitro-
3-phenylpentyl)-4-methoxyaniline. Yellow solid (55%)
m.p. 143–145 °C; 1H NMR (400 MHz, CDCl3): δ 0.75 (3H, t, J =
7.3), 1.63 (1H, dqd, J = 13.5, 7.3, 3.5), 1.81 (1H, ddq, J = 13.5,
11.3, 7.3), 3.53–3.70 (1H, m), 3.65 (3H, s), 4.44–4.56 (1H, m),
5.09 (1H, dd, J = 11.3, 3.3), 5.18 (1H, d, J = 9.5), 6.11–6.25 (2H,
m), 6.56–6.66 (2H, m), 7.11 (1H, dd, J = 7.7, 4.6), 7.20–7.34
(5H, m), 7.40 (1H, dd, J = 7.7, 1.9), 8.20 (1H, dd, J = 4.6, 1.9);
13C NMR (101 MHz, CDCl3): δ 11.6 (CH3), 25.2 (CH2), 48.1
(CH), 55.6 (CH3), 55.7 (CH3), 95.1 (CH), 114.3 (2C, CH), 115.0
(2C, CH), 123.5 (CH), 128.0 (CH), 128.7 (2C, CH), 128.8 (2C,
CH), 134.7 (q), 136.1 (CH), 136.8 (q), 138.8 (q), 142.8 (q), 149.7
(CH), 152.6 (q); IR νmax (neat) 3414, 2934, 1548, 1241 cm
−1;
HRMS (ES) calcd for C23H25BrN3O3
+, [M + H+] 469.1079 found
469.1080.
Entry 7 (1S*,2S*,3R*)-N-(1-(2-bromophenyl)-2-nitro-3-p-tolyl-
pentyl)-4-methoxybenzenamine. Yellow solid m.p. 143–145 °C;
1H NMR (400 MHz, CDCl3): δ 0.77 (3H, t, J = 7.3), 1.63 (1H,
dqd, J = 13.6, 7.3, 3.6), 1.79 (1H, ddq, J = 13.6, 11.7, 7.3), 2.35
(3H, s), 3.63 (1H, app. td, J = 11.3, 3.5), 3.68 (3H, s), 4.64 (1H,
dd, J = 10.3, 3.3), 5.07 (1H, dd, J = 11.2, 3.3), 5.25 (1H, d, J =
10.3), 6.19–6.29 (2H, m), 6.59–6.69 (2H, m), 7.04–7.21 (7H, m),
7.49 (1H, dd, J = 7.8, 1.0); 13C NMR (101 MHz, CDCl3): δ 11.6
(CH3), 21.1 (CH3), 25.2 (CH2), 47.7 (CH), 55.6 (OCH3), 56.0
(CH), 95.6 (CH), 114.3 (2C, CH), 114.8 (2C, CH), 123.1 (q),
127.4 (CH), 128.1 (CH), 128.7 (2C, CH), 129.4 (2C, CH), 129.6
(CH), 133.1 (CH), 134.0 (q), 137.0 (q), 137.4 (q), 139.5 (q), 152.3
(q); IR νmax (neat) 3415, 2933, 1550, 1243 cm
−1; HRMS (ES)
calcd for C25H28BrN2O3
+, [M + H+] 483.1278 found 483.2181.
Entry 8 (1S*,2S*,3R*)-N-(1-(2-bromophenyl)-2-nitro-3-o-tolyl-
pentyl)-4-methoxybenzenamine. Yellow solid (62%) m.
p. 119–121 °C; 1H NMR (500 MHz, CDCl3): δ 0.72 (3H, t, J =
7.3), 1.77 (1H, ddq, J = 12.7, 11.2, 7.3), 2.07 (1H, dqd, J = 12.7,
7.3, 4.0), 2.39 (3H, s), 3.71 (3H, s), 4.10 (1H, app. td, J = 11.1,
3.9), 5.28 (1H, dd, J = 11.1, 3.3), 5.30 (1H, d, J = 10.2), 5.50 (1H,
dd, J = 10.2, 3.3), 6.54–6.58 (2H, m), 6.74–6.78 (2H, m),
7.10–7.15 (5H, m), 7.17–7.22 (2H, m), 7.23–7.27 (1H, m), 7.60
(1H, d, J = 8.0); 13C NMR (126 MHz, CDCl3): δ 11.2 (CH3), 19.9
(CH3) 25.2 (CH2), 42.0 (CH), 55.7 (CH3), 55.8 (CH), 95.5 (CH),
114.5 (2C, CH), 115.1 (2C, CH), 123.3 (q), 125.8 (CH), 126.6
(CH), 127.2 (CH), 127.5 (CH), 128.6 (CH), 130.0 (CH), 130.8
(CH), 133.3 (CH), 136.6 (q), 137.1 (q), 137.4 (q), 139.5 (q), 152.6
(q); IR νmax (neat) 3399, 2965, 1549, 1258 cm
−1; HRMS (EI)
calcd for C25H27BrN2O3
+, [M+] 482.1199 found 482.1185; Anal.
calcd for C25H27BrN2O3: C, 62.12; H, 5.63; N, 5.80; found: C,
62.09; H, 5.90; N, 5.63%.
Entry 9 (1S*,2S*,3R*)-N-(1-(2-bromophenyl)-3-(4-fluoro-
phenyl)-2-nitropentyl)-4-methoxybenzenamine. Yellow solid
(62%) m.p. 117–119 °C; 1H NMR (400 MHz, CDCl3): δ 0.76 (3H,
t, J = 7.3), 1.65 (1H, dqd, J = 13.4, 7.3, 3.5), 1.77 (1H, dqd, J =
13.4, 11.4, 7.3), 3.67 (1H, m), 3.68 (3H, s), 4.57 (1H, app. d, J =
6.5), 5.03 (1H, dd, J = 11.2, 3.4), 5.23 (1H, d, J = 9.3), 6.20–6.28
(2H, m), 6.60–6.70 (2H, m), 6.96–7.04 (2H, m), 7.05–7.14 (2H,
m), 7.14.7.22 (1H, m), 7.22–7.32 (2H, m), 7.49 (1H, d, J = 8.1);
13C NMR (101 MHz, CDCl3): δ 11.6 (CH3), 25.2 (CH2), 47.4
(CH), 55.6 (CH3), 56.0 (CH), 95.4 (CH), 114.3 (2C, CH), 114.9
(2C, CH), 115.7 (d, JCF = 21.6, 2C, CH), 123.1 (q), 127.4 (CH),
128.2 (CH), 129.8 (CH), 130.4 (d, JCF = 7.2, 2C CH), 132.9 (d,
JCF = 3.2, q), 133.2 (q), 136.6 (q), 139.3 (q), 152.4 (q), 162.3 (d,
JCF = 246.7, q);
19F NMR (376 MHz, CDCl3) δ −114.70 (m); IR
νmax (neat) 3413, 2967, 1550, 1228 cm
−1; HRMS (ES) calcd for
C24H25BrFN2O3
+, [M + H+] 487.1027 found 487.1026.
General procedure for the synthesis of indolines 7 (Table 1)
To a stirred mixture of syn,syn-β-nitroamine 3 (0.50 mmol) and
Zinc (4.00 mmol) in EtOH (7.5 mL) at 0 °C was added conc.
hydrochloric acid (10 mmol). The mixture was stirred at this
temperature for 5 min then at RT until the reaction was com-
plete by TLC analysis (approximately 1 h). The reaction was
quenched by the addition of EtOAc and saturated aq. NaHCO3.
The layers were separated, and the aqueous phase was
extracted with EtOAc. The organic layers were combined, and
the solvent was removed in vacuo to provide crude 1,2-diamine.
To a stirred mixture of sodium tert-butoxide (1.00 mmol),
palladium tetrakistriphenylphosphine (0.025 mmol) in
toluene (1 ml) under nitrogen at RT was added a solution of
crude 1,2-diamine in toluene (1.5 ml). The reaction vessel was
heated at 90 °C until the reaction was complete by TLC analy-
sis (approximately 16 to 24 h). Reaction cooled to RT and fil-
tered thought celite and concentrated to give a brown oil.
Purification by flash chromatography using basic Alumina or
aminopropyl (NH2) silica yielded the indoline 7 (Table 1).
7bb Entry 1 (1S*,2S*,1′R*)-1-N-(4-methoxyphenyl)-2-(1′-
phenylpropyl)indolin-3-amine. Yellow oil (64%); 1H NMR
(600 MHz, C6D6): δ 0.75 (3H, t, J = 7.3), 1.77 (1H, ddq, J = 13.1,
11.5, 7.3), 1.65 (1H, dqd, J = 13.1, 7.3, 3.6), 3.10 (1H, ddd, J =
11.3, 10.4, 3.6), 3.16 (1H, d, J = 10.7), 3.31 (3H, s), 3.51 (1H,
ddd, J = 10.4, 6.6, 3.0), 3.62 (1H, d, J = 3.0), 4.14 (1H, dd, J =
10.7, 6.6), 5.94–5.97 (2H, m), 6.58 (1H, d, J = 7.8), 6.60–6.65
(3H, m), 6.91 (1H, d, J = 7.2), 7.07–7.12 (2H, m), 7.13–7.17 (4H,
m); 13C NMR (151 MHz, C6D6): δ 10.7 (CH3), 24.9 (CH2), 45.7
(CH), 53.8 (CH3), 57.9 (CH), 67.5 (CH), 109.1 (CH), 113.5 (2C,
CH), 115.4 (2C, CH), 118.0 (CH), 123.1 (CH), 125.1 (CH), 127.1
(2C, CH), 127.5 (CH), 127.7 (2C, CH), 131.1 (q), 140.5 (q), 141.6
(q), 149.2 (q), 151.8 (q); IR νmax (neat) 3367, 2928, 1234 cm
−1;
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HRMS (EI) calcd for C24H26N2O
+, [M+] 358.2040 found
358.2028.
Entry 2 (1S*,2S*,1′R*)-5-fluoro-N-(4-methoxyphenyl)-2-(1′-
phenylpropyl)indolin-3-amine. Yellow oil (53%); 1H NMR
(600 MHz, C6D6): δ 0.76 (3H, t, J = 7.3), 1.39 (1H, ddq, J = 13.2,
11.4, 7.3), 1.61 (1H, dqd, J = 13.2, 7.3, 3.6), 3.03–3.07 (2H, m),
3.30 (3H, s), 3.51 (2H, m), 3.98 (1H, dd, J = 10.2, 6.6), 5.89–5.92
(2H, m), 6.58 (1H, dd, J = 8.5, 4.2), 6.58–6.61 (2H, m), 6.66 (1H,
dd, J = 8.0, 2.6), 6.78 (1H, dd, J = 8.7, 2.6), 7.09–7.17 (5H, m);
13C NMR (151 MHz, C6D6): δ 11.9 (CH3), 26.2 (CH2), 46.9 (CH),
54.9 (CH3), 59.2 (CH), 69.3 (CH), 115.0 (d, JCF = 31.2, CH),
116.9 (d, JCF = 23.2, CH), 114.8 (2C, CH), 114.9 (d, JCF = 23.2,
CH), 116.8 (2C, CH), 126.5 (CH), 128.2 (CH), 128.4 (2C, CH),
128.9 (CH), 133.7 (d, JCF = 7.3, q), 141.2 (q), 142.6 (q), 146.4 (q),
153.3 (q), 157.1 (d, JCF = 236.0, q); IR νmax (neat) 3365, 2961,
1509, 1236 cm−1; HRMS (CI) calcd for C24H26FN2O
+, [M + H+]
377.2029 found 377.2028.
Entry 3 (1S*,2S*,1′R*)-5-methoxy-N-(4-methoxyphenyl)-2-
(1′-phenylpropyl)indolin-3-amine. Light yellow oil (40%);
1H NMR (400 MHz, CDCN): δ 0.72 (3H, t, J = 7.4), 1.66 (1H,
ddq, J = 13.1, 11.5, 7.3), 1.86–1.94 (1H, m), 3.02 (1H, app. td,
J = 10.4, 3.5), 3.58 (3H, s), 3.66 (3H, s), 3.88–4.03 (2H, m), 4.28
(1H, dd, J = 9.5, 7.0), 4.55 (1H, br. s), 6.25–6.36 (2H, m), 6.52
(1H, s), 6.60–6.69 (4H, m), 7.13–7.27 (5H, m); 13C NMR
(101 MHz, CDCN): δ 10.8 (CH3), 25.6 (CH2), 46.7 (CH), 55.0
(CH3), 57.7 (CH3), 57.7 (CH), 68.2 (CH), 110.1 (CH), 110.2 (CH),
113.1 (CH), 114.2 (2C, CH), 115.0 (2C, CH), 125.7 (CH), 127.7
(2C, CH), 128.3 (2C, CH), 133.1 (q), 141.7 (q), 142.9 (q), 144.6
(q), 151.7 (q), 152.6 (q); IR νmax (neat) 3360, 2931, 1510 cm
−1;
HRMS (CI) calcd for C25H28N2O2
+, [M+] 388.2145 found
388.2151.
Entry 5 (1S*,2S*,1′R*)-N-(4-methoxyphenyl)-6-methyl-2-(1′-
phenylpropyl)indolin-3-amine. Light yellow oil (62%); 1H
NMR (400 MHz, CDCN): δ 0.70 (3H, t, J = 7.4), 1.66 (1H, ddq,
J = 13.4, 11.5, 7.3), 1.83–1.92 (1H, m), 2.21 (3H, s), 2.93–3.09
(1H, m), 3.65 (3H, s), 3.83–4.02 (2H, m), 4.28 (1H, app. t, J =
8.2), 4.74 (1H, br. s), 6.23–6.32 (2H, m), 6.36 (1H, d, J = 7.5),
6.53 (1H, s), 6.56–6.67 (2H, m), 6.72–6.82 (1H, m), 7.10–7.28
(5H, m); 13C NMR (101 MHz, CDCN): δ 10.8 (CH3), 20.4 (CH3),
25.5 (CH2), 46.7 (CH), 54.9 (CH3), 57.0 (CH), 67.8 (CH), 110.3
(CH), 114.1 (2C, CH), 114.8 (2C, CH), 118.6 (CH), 123.2 (CH),
125.7 (CH), 127.7 (2C, CH), 128.3 (2C, CH), 129.0 (q), 138.0 (q),
141.8 (q), 142.9 (q), 151.0 (q), 151.6 (q); IR νmax (neat) 3365,
2929, 1511, 1236 cm−1; HRMS (EI) calcd for C25H26N2O
+, [M+]
372.2196 found 372.2207.
Entry 7 (1S*,2S*,1′R*)-N-(4-methoxyphenyl)-2-(1′-p-tolyl-
propyl)indolin-3-amine. Oil, (64%); 1H NMR (400 MHz,
CDCl3): δ 0.81 (3H, t, J = 7.3), 1.77 (1H, ddq, J = 13.1, 11.5, 7.3),
1.65 (1H, dqd, J = 13.1, 7.3, 3.6), 2.37 (3H, s), 3.02–3.19 (1H,
m), 3.40 (1H, br. s), 3.75 (3H, s), 3.94 (1H, dd, J = 9.8, 6.5), 4.16
(1H, m), 4.34 (1H, d, 6.5), 6.19–6.32 (2H, m), 6.60–6.72 (3H,
m), 6.75 (1H, d, J = 7.8), 6.94 (1H, d, J = 7.3), 7.05–7.18 (5H, m);
13C NMR (101 MHz, CDCN): δ 11.8 (CH3), 21.0 (CH3), 25.9
(CH2), 46.3 (CH), 55.7 (CH3), 59.0 (CH), 68.8 (CH), 110.1 (CH),
114.5 (2C, CH), 116.3 (2C, CH), 119.1 (CH), 124.1 (CH), 128.5
(2C, CH), 128.6 (CH), 128.9 (2C, CH), 131.9 (q), 135.6 (q), 139.4
(q), 141.7 (q), 150.0 (q), 152.4 (q); IR νmax (neat) 3408, 2928,
1510 cm−1; HRMS (EI) calcd for C25H28N2O
+, [M+] 372.2196
found 372.2203.
Entry 8 (1S*,2S*,1′R*)-N-(4-methoxyphenyl)-2-(1′-o-tolyl-
propyl)indolin-3-amine. Oﬀ white solid (66%) m.p. 55–57 °C;
1H NMR (400 MHz, CDCl3): δ 0.60 (3H, t, J = 7.3), 1.52–1.70
(1H, m), 1.89–1.99 (1H, m), 2.39 (3H, s), 3.32–3.50 (1H, m),
3.71 (3H, s), 3.79–3.96 (2H, m), 4.22 (1H, br. d, J = 11.1), 4.96
(1H, dd, J = 11.0, 6.9), 6.46 (1H, d, J = 7.8), 6.49–6.75 (1H, m),
6.72–6.84 (4H, m), 6.91–6.99 (1H, m), 7.03 (1H, d, J = 7.3),
7.11–7.18 (1H, m), 7.19–7.28 (2H, m), 7.29–7.38 (1H, m); 13C
NMR (101 MHz, CDCN): δ 10.4 (CH3), 19.4 (CH3), 26.1 (CH2),
40.6 (CH), 54.9 (CH3), 56.3 (CH), 68.0 (CH), 109.5 (CH), 114.4
(2C, CH), 115.3 (2C, CH), 117.6 (CH), 123.8 (CH), 125.6 (CH),
125.9 (CH), 126.2 (CH), 128.1 (CH), 129.8 (CH, 131.7 (q), 137.5
(q), 141.3 (q), 141.8 (q), 150.5 (q), 151.9 (q); IR νmax (neat) 3365,
2929, 1511, 1236 cm−1; HRMS (CI) calcd for C25H27N2O
+,
[M + H+] 373.2280 found 373.2285.
Entry 9 (1S*,2S*,1′R*)-2-(1′-(4-fluorophenyl)propyl)-N-
(4-methoxyphenyl)indolin-3-amine. Oil (70%); 1H NMR
(400 MHz, CDCN): δ 0.50 (3H, t, J = 7.3), 1.35–1.49 (1H, m),
1.63–1.72 (1H, m), 2.81 (1H, app td, J = 10.6, 3.5), 3.45 (3H, s),
3.71 (1H, ddd, J = 10.0, 6.9, 3.3), 3.77 (1H, d, J = 10.6), 4.11
(1H, dd, J = 10.5, 6.9), 4.64 (1H, m, J = 2.0), 6.05–6.14 (2H, m),
6.29–6.36 (1H, m), 6.38–6.45 (2H, m), 6.50 (1H, d, J = 7.8), 6.68
(1H, d, J = 6.8), 6.70–7.06 (5H, m); 13C NMR (101 MHz, CDCN):
δ 12.1 (CH3), 27.1 (CH2), 47.3 (CH), 56.2 (CH3), 58.4 (CH), 68.9
(CH), 111.0 (CH), 115.4 (d, JCF = 21.6, 2C, CH), 115.5 (3C, CH),
119.2 (2C, CH), 124.8 (CH), 129.5 (CH), 131.2 (d, JCF = 8.0, 2C,
CH), 132.9 (q), 140.2 (d, JCF = 3.2, q), 143.0 (q), 152.1 (q), 153.0
(q), 162.3 (d, JCF = 241.3, q);
19F NMR (376 MHz, CDCN) δF
−119.1 (s); IR νmax (neat) 3366, 2931, 1510 cm−1; HRMS (EI)
calcd for C24H25FN2O
+, [M+] 376.1945 found 376.1940.
9 (1R*,2S*)-N-(1-(2-Bromophenyl)-2-nitro-3-phenylpropyl)-4-
methoxyaniline.38 Yellow solid (68%) m.p. 105–107 °C; 1H
NMR (600 MHz, CDCl3): δ 3.19 (1H, app. d, J = 14.7), 3.48 (1H,
dd, J = 15.0, 11.4), 3.71 (3H, s), 4.52 (1H, br. s), 5.36 (1H, ddd,
J = 11.4, 5.0, 2.8), 5.40 (1H, d, J = 5.0), 6.55 (2H, d, J = 8.8),
6.69–6.78 (2H, m), 7.09 (2H, d, J = 7.3), 7.19–7.32 (5H, m), 7.48
(1H, d, J = 8.1), 7.65 (1H, d, J = 8.1); 13C NMR (151 MHz,
CDCl3): δ 33.9 (CH2), 55.6 (CH3), 60.9 (CH), 90.9 (CH), 114.8
(2C, CH), 115.7 (2C, CH), 123.1 (q), 127.3 (CH), 128.1 (CH),
128.6 (2C, CH), 128.8 (2C, CH), 129.5 (CH), 130.1 (CH), 133.8
(CH), 135.5 (q), 136.1 (q), 139.5 (q), 153.2 (q); IR νmax (neat)
3395, 2934, 1549, 1236 cm−1; HRMS (ES) calcd for
C22H22BrN2O3
+, [M + H+] 441.0809 found 441.0808.
10 (1R*,2S*)-2-Benzyl-N-(4-methoxyphenyl)indolin-3-amine.
Prepared by the ‘General Procedure for the synthesis of indo-
line 7’. Oﬀ white solid (75%), m.p. 83–85 °C; 1H NMR
(600 MHz, CDCl3): δ 2.81 (1H, dd, J = 13.4, 9.4), 3.05 (1H, dd,
J = 13.4, 4.8), 3.67 (1H, br. s), 3.80 (3H, s), 3.85 (1H, br. s), 3.87
(1H, app. dt, J = 9.3, 4.7), 4.77 (1H, dd, J = 4.4), 6.55 (2H, dd,
J = 8.8), 6.65 (1H, dd, J = 7.7), 6.73–6.83 (3H, m), 7.16 (1H, t, J =
7.7), 7.22–7.34 (4H, m), 7.34–7.42 (2H, m); 13C NMR (151 MHz,
CDCN): δ 41.0 (CH2), 55.8 (CH3), 61.8 (CH), 66.8 (CH), 109.9
(CH), 115.0 (2C, CH), 115.0 (2C, CH), 118.8 (CH), 125.5 (CH),
Paper Organic & Biomolecular Chemistry
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126.6 (CH), 128.7 (2C, CH), 129.2 (q), 129.3 (CH), 129.3 (2C,
CH), 138.5 (q), 141.2 (q), 149.9 (q), 152.4 (q); IR νmax (neat)
3373, 2932, 1510 cm−1; HRMS (EI) calcd for C25H28N2O
+, [M+]
330.1732 found 330.1741.
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